LentiArray™ CRISPR Positive Control Lentivirus, human HPRT, with GFP, 100 μL - Citations

LentiArray™ CRISPR Positive Control Lentivirus, human HPRT, with GFP, 100 μL - Citations

View additional product information for LentiArray™ CRISPR Positive Control Lentivirus, human HPRT, with GFP - Citations (A32830, A32060)

Showing 1 product Citations

Citations & References
Abstract
A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain.
AuthorsSredni ST, Suzuki M, Yang JP, Topczewski J, Bailey AW, Gokirmak T, Gross JN, de Andrade A, Kondo A, Piper DR, Tomita T
JournalPediatr Blood Cancer
PubMed ID28398638
Malignant rhabdoid tumors (MRTs) are deadly embryonal tumors of the infancy. With poor survival and modest response to available therapies, more effective and less toxic treatments are needed. We hypothesized that a systematic screening of the kinome will reveal kinases that drive rhabdoid tumors and can be targeted by specific ... More